Zentiva as is a Slovakia-based company engaged in generic pharmaceuticals business sector. The Company develops, manufactures, and sells generic medicinal products, primarily used in primary care sector. Its portfolio includes preparations for various therapeutic areas, including cardiovascular system, womenâ€™s healthcare, respiratory system, antimicrobials, urological system, central nervous system, pain, and gastrointestinal system.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume

End-of-day quote Bratislava S.E.

More quotes

End-of-day quote Bratislava S.E. Other stock markets 2026-06-08			5-day change	1st Jan Change
31.00 ^EUR	+3.33%		+3.33%	+3.33%

03-16	Zentiva publishes 2025 sustainability report reinforcing commitment to people, partners and the planet	RE
02-23	Zentiva as responds to EU court decision on UWWTD	RE

Market Cap	243M 210M 193M 181M 339M 23.1B 345M 2.28B 890M 11.24B 912M 893M 38.93B	P/E Ratio 2017	7.27x	P/E Ratio 2018	177x
Enterprise Value	242M 209M 193M 180M 338M 23.03B 343M 2.28B 888M 11.21B 909M 890M 38.81B	EV / Sales 2017	3.97x	EV / Sales 2018	11.2x
Free-Float	4.05%	Yield 2017	13.8%	Yield 2018	-

03-16	Zentiva publishes 2025 sustainability report reinforcing commitment to people, partners and the planet	RE
02-23	Zentiva as responds to EU court decision on UWWTD	RE
25-09-11	Deals of the Day-Mergers and acquisitions	RE
25-09-11	Deals of the Day-Mergers and acquisitions	RE
25-09-11	Zentiva announces sale from Advent to GTCR	RE
25-09-11	Private equity firm Advent to sell drugmaker Zentiva to GTCR	RE
25-09-11	Deals of the Day-Mergers and acquisitions	RE
25-09-10	Private equity GTCR strikes $4.8 billion deal to buy Zentiva, FT reports	RE
25-09-10	Advent strikes $4.8 billion deal to sell Zentiva to GTCR, FT reports	RE
25-09-10	Advent strikes EUR4.1bn deal to sell generic drugmaker Zentiva to GTCR - FT	RE
25-08-20	India's Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5 billion, Economic Times reports	RE
25-08-20	India's Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5 billion, Economic Times reports	RE
13-02-20	Wood Pharma Holding a.s. completed the acquisition of Hlohovec Production Plant from Zentiva A.S..	CI

1 day	+3.33%
1 week	+3.33%
3 months	+3.33%
6 months	+3.33%
Current year	+3.33%

Zentiva, Stock

Stocks

1SKF401E

SK1120004439

Pharmaceuticals

Valuation: Zentiva,

Chart: Zentiva,

Latest news : Zentiva,

Press Releases: Zentiva,

Quotes and Performance

Course Extremes

Managers and Directors: Zentiva,

Generic Pharmaceuticals

Financials

Company Profile

Quotes

1 week	31	31
1 month	30	31
Current year	29	33
1 year	29	45
3 years	24	45
5 years	11	45
10 years	11	370

Manager	Title	Age	Since
Thomas Cornelis Koene CEO	Chief Executive Officer	-	2015-11-11
Hacho Agop Hatchikian PRN	Corporate Officer/Principal	-	2022-08-17

Director	Title	Age	Since
Kenneth Lynard BRD	Director/Board Member	58	2020-11-14
Mojmír Krutý BRD	Director/Board Member	-	2013-07-07
Martin Albert BRD	Director/Board Member	-	2018-10-17

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ZENTIVA,	+3.33%	+3.33%	+3.33%	+3.33%	57.88M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+0.75%	+1.43%	+7.13%	+83.44%	44.96B
OTSUKA HOLDINGS CO., LTD.	-0.20%	-3.59%	+38.01%	+87.26%	33.53B
CIPLA LIMITED	+0.44%	-0.85%	-7.55%	+44.74%	11.67B
ZYDUS LIFESCIENCES LIMITED	-0.11%	+1.44%	+12.86%	+116.61%	11.62B
KRKA, D. D.	+0.59%	+0.78%	+36.70%	+126.43%	8.97B
GEDEON RICHTER	+2.40%	+0.08%	+17.77%	+43.22%	6.89B
ONO PHARMACEUTICAL CO., LTD.	-1.12%	-0.56%	+40.12%	-18.60%	6.55B
GLENMARK PHARMACEUTICALS LIMITED	+1.37%	+0.35%	+32.58%	+240.43%	6.32B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	+0.51%	-3.04%	-42.24%	-5.52%	5.12B
Average	+0.80%	-0.42%	+13.87%	+72.13%	13.57B
Weighted average by Cap.	+0.42%	-0.96%	+17.40%	+83.69%

	2017	2018
Net sales	143M 123M 114M 106M 199M 13.56B 202M 1.34B 523M 6.6B 535M 524M 22.86B	36.17M 31.24M 28.79M 26.95M 50.51M 3.44B 51.29M 340M 133M 1.67B 136M 133M 5.79B
Net income	77.98M 67.35M 62.06M 58.09M 109M 7.41B 111M 733M 286M 3.61B 293M 286M 12.49B	2.29M 1.98M 1.82M 1.71M 3.2M 218M 3.25M 21.52M 8.39M 106M 8.59M 8.41M 367M
Net Debt	-0.09 -0.08 -0.07 -0.07 -0.13 -8.74 -0.13 -0.86 -0.34 -4.26 -0.35 -0.34 -14.74	-0.77 -0.67 -0.62 -0.58 -1.08 -73.57 -1.1 -7.27 -2.84 -35.81 -2.9 -2.84 -123.99